Pharmacologic approaches to glycemic treatment ( DrugBank: - )
1 disease
| ID | Disease name (Link within this page) | Number of trials |
|---|---|---|
| 298 | Hereditary pancreatitis | 1 |
298. Hereditary pancreatitis
Clinical trials : 95 / Drugs : 148 - (DrugBank : 51) / Drug target genes : 53 - Drug target pathways : 142
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05764629 (ClinicalTrials.gov) | September 1, 2021 | 18/2/2023 | An Observational Study on Post-chronic Pancreatitis Diabetes Mellitus | An Observational Study of Risk Factors Influencing Glycemic Status and Optimized Treatment on Post-chronic Pancreatitis Diabetes Mellitus | Chronic Pancreatitis;Diabetes Mellitus | Diagnostic Test: blood test;Drug: pharmacologic approaches to glycemic treatment | Changhai Hospital | NULL | Active, not recruiting | N/A | N/A | All | 324 | China |